Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-24

Clinical Trial Update: COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI [NA]

View source ↗

Summary

This terminated study investigated high-dose proton pump inhibitors in COPD patients with gastroesophageal reflux disease and reported COPD exacerbations after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton pump inhibitor (high-dose) (proton pump inhibitor)

Snippet

Sponsor: University of Florida | Conditions: Gastroesophageal Reflux, Chronic Obstructive Pulmonary Disease | NA | Status: TERMINATED | Results posted: 2012-07-24